Pharmaceutical companies are seeking clarification on tariffs imposed under the new US-EU trade agreement. Analysts caution that sector-specific punitive levies could jeopardise the entire deal, according to a CNBC report.Significant ambiguity surrounds the precise definitions and classifications of pharmaceutical goods within the framework of the trade truce finalised on Sunday. This agreement…
Asia-Pacific stock markets began the trading week with a mixed and cautious performance on Monday, as investors eagerly awaited…
Recent activity in the wheat market has led to price fluctuations within a narrow band. Prices have hovered around 540…
European stock markets rallied on Monday, with the regional Stoxx 600 index climbing to a four-month high, as investors…
The United States and the European Union announced on Sunday a broad framework for a new trade agreement aimed…
The Australian Securities and Investments Commission (ASIC) has issued a formal warning against Bitget for promoting and offering unlicensed…
Tesla Inc (NASDAQ: TSLA) has been a rocky ride lately, shedding nearly 13% over the past two months amid…
This week’s most notable news in Latin America is that the Brazilian financial system moves closer to global trends…
Vietnam has officially launched NDAChain, a national blockchain platform designed to enhance digital security across government and private services.…